Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02139514 · ClinicalTrials.gov registry record · NA

Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders

A NA study of Autism Spectrum Disorders, sponsored by Yale University.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02139514 is a NA study of Autism Spectrum Disorders that has completed, run by Yale University. The registered enrollment target is 10 participants, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02139514, a NA study of Autism Spectrum Disorders, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to predict and explain on the basis of brain function and structure the behavioral and brain effects of an evidence-based intervention for adults with high-functioning autism, Virtual Reality-Social Cognition Training (Kandalaft et al., 2012; Journal of Autism and Developmental Disorders). Adults with autism will be randomly assigned to receive either (a) two hours per week of intervention services for five weeks, or (b) a treatment as usual control. The intervention will focus on enhancing social skills, social cognition, and social functioning. Outcome measures will evaluate changes in these social skills, cognition, and functioning using standardized assessments. We will perform structural and functional magnetic resonance imaging (MRI) scans at three time points-before, during, and after treatment (i.e., Time Point #1, 2, and 3).

Conditions Studied

Interventions

  • BEHAVIORAL Virtual Reality Social Cognition Training

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-01
Est. Completion 2016-06
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02139514

The ClinicalTrials.gov registry entry for NCT02139514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (94% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality Social Cognition Training is the first listed.

NCT02139514 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02139514 about?

NCT02139514 is a clinical study titled "Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders". The purpose of this study is to predict and explain on the basis of brain function and structure the behavioral and brain effects of an evidence-based intervention for adults with high-functioning autism, Virtual Reality-Social Cognition Training (Kandalaft et al., 2012; Journal of Autism and Develo...

What is the current status of trial NCT02139514?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-01. Estimated completion is 2016-06.

What conditions does trial NCT02139514 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT02139514?

The interventions under investigation include: Virtual Reality Social Cognition Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02139514?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02139514 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.